Clinical trial
Impact of Hybrid Coronary Revascularization on Antiplatelet Effect of Aspirin and Clopidogrel
NCT02293928 is registered in ClinicalTrials.gov with Aarhus University Hospital Skejby as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Hybrid Coronary Revascularization on Antiplatelet Effect of Aspirin and Clopidogrel
- Lead sponsor
- Aarhus University Hospital Skejby
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- April 30, 2013
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.